How many insider declarations has Pavlov George filed?

Pavlov George has filed 2 public insider declarations with SEC (Form 4).

What is Pavlov George's role?

Pavlov George's reported role is not specified by the regulator across the filings.

Which companies does Pavlov George report trades for?

Pavlov George reports trades for MapLight Therapeutics, Inc..

What is Pavlov George's declared buy vs sell volume?

Across the available history, declared buys total 157k€ and disposals 0.

← Executives ★ Sign in to follow

PG

Pavlov George

OFFICERM

·SEC (Form 4)

MapLight Therapeutics, Inc.

0

申报总数

0

公司

€157,192

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

100%

T+90 平均收益

+60.8%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Pavlov George. Director active across 1 company, notably MapLight Therapeutics, Inc.. Aggregated, 2 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €157k. History available since 18 February 2026. The latest transaction was disclosed on 18 February 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Pavlov George

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

MapLight Therapeutics, Inc. (US)

申报2 总计

◆

Pavlov George

Director高管2026年6月23日MapLight Therapeutics, Inc.

0SEC ↗

3,932 股Voting Common StockSEC:0001470798-26-000004:0

▲

Pavlov George

Director高管2026年2月18日MapLight Therapeutics, Inc.

US$186,30235SEC ↗

10,658 股@ US$17.48100.0% 占其流量Voting Common StockSEC:0001470798-26-000002:0

标准退出：2026年5月19日 (T+90)

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

PG

Pavlov George

OFFICERM

·SEC (Form 4)

MapLight Therapeutics, Inc.

0

申报总数

0

公司

€157,192

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

100%

T+90 平均收益

+60.8%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Pavlov George. Director active across 1 company, notably MapLight Therapeutics, Inc.. Aggregated, 2 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €157k. History available since 18 February 2026. The latest transaction was disclosed on 18 February 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.